#Zepbound
articles
Companies
Eli Lilly's GLP-1 Juggernaut Powers 48% Revenue Jump, Eyes Next Obesity Blockbuster
Quarterly sales topped $23 billion as Mounjaro and Zepbound dominate the obesity drug market. With a new oral pill and a...
Companies
Novo Nordisk Sues Eli Lilly Over ‘Unfair’ Comparison of Weight-Loss Drugs
The Danish drugmaker claims Eli Lilly’s advertising for Zepbound and Mounjaro used outdated Wegovy doses, misleading pat...